HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
ID: 348961Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348961

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-225.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled the "HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program," aimed at supporting early-stage investigators in the field of HIV/AIDS research. This program provides three years of salary and research support to individuals who have recently completed their professional degrees or residency training, with a focus on mentorship and research utilizing NHPs as preclinical models. The initiative is designed to enhance career development in HIV/AIDS translational studies, aligning with NIH's strategic goals to advance HIV therapies, develop cures, and address complications associated with HIV. Applications are due by September 8, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-225.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-225-Full-Announcement.html
    PAR-23-225.html
    The National Institutes of Health (NIH) has announced a funding opportunity titled the "HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program," aiming to support early-stage investigators in HIV/AIDS research. The program provides three years of salary and research support to individuals who have recently completed their professional degrees or residency training, focusing on mentorship and research using NHPs as preclinical models. This initiative emphasizes long-term career development in HIV/AIDS translational studies, aligning with NIH's strategic goals to advance HIV therapies, cures, and address complications associated with HIV. Applications are invited from diverse eligible organizations and individuals, provided they have adequate experience and postdoctoral training. Participants are expected to dedicate 75% of their professional effort to the project, with a strong emphasis on comprehensive mentoring and training. The deadline for applications is September 8, 2025, and the process includes rigorous review criteria to ensure scientific and technical merit. The program aims not only to enhance individual careers but also to strengthen the HIV/AIDS research community by promoting the engagement of new, capable investigators in critical areas of study, thereby addressing public health priorities effectively.
    Similar Opportunities
    Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research, aimed at providing ongoing support for breeding colonies of Specific Pathogen Free (SPF) macaques essential for HIV/AIDS research. The funding will facilitate the breeding, maintenance, and allocation of these macaques to qualified researchers, ensuring rigorous health and genetic monitoring to mitigate risks associated with certain viruses that could affect research outcomes. These colonies play a critical role in advancing studies related to vaccine development and co-infection, underscoring their importance in the fight against HIV/AIDS. Interested applicants, specifically public and state-controlled institutions of higher education, must submit their proposals by January 7, 2027, and can find further details and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)" aimed at supporting the development, production, and distribution of nonhuman primate-specific immunologic reagents. This initiative, led by the National Institute of Allergy and Infectious Diseases (NIAID), seeks to enhance preclinical research in nonhuman primate models to accelerate advancements in cures, vaccines, and treatments for immune-mediated diseases and emerging infectious diseases. The estimated total program funding is $1,300,000, with one award expected, and applications are anticipated to be solicited starting in late August 2025, with a closing date in late October 2025. Interested applicants can reach out to Dr. Shilpa Kulkarni at shilpa.kulkarni@nih.gov or call 240-747-7365 for further information.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Multidisciplinary Studies of HIV/AIDS and Aging," aimed at exploring the intersection of HIV and aging. This initiative seeks to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, while also improving strategies for testing, prevention, and treatment of HIV-related health complications. Given the increasing number of older adults living with HIV, this research is crucial for addressing public health challenges and improving healthcare delivery across diverse populations. The funding supports exploratory research under the R21 mechanism, with a maximum budget of $275,000 for two years, and applications are due between May 2025 and January 2027. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-355.html.
    NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) to enhance the training of a skilled workforce in biomedical, behavioral, and clinical research, particularly focusing on HIV research. This program aims to support mentoring and hands-on research experiences for participants, including undergraduate and graduate students, medical residents, and early-career faculty, with an emphasis on HIV prevention, health disparities, and neuroscience research. Successful applications must demonstrate a clear educational framework, detailed mentoring plans, and evaluation metrics, with a maximum annual budget of $200,000 available over a project period not exceeding five years. Applications are due by September 7, 2026, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research related to HIV/AIDS and communication disorders. This initiative encourages applications that address high-priority research areas defined by the NIH Office of AIDS Research, focusing on the impact of HIV on hearing, balance, taste, smell, voice, speech, and language, with a budget limit of $275,000 for a two-year project period. Eligible applicants include a diverse range of institutions and organizations, and only low-risk clinical trials that do not require FDA oversight will be supported. Interested parties can find more information and application details at the NIH grants website, with deadlines for submissions ranging from May 2025 to January 2028.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to HIV/AIDS within the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative encourages applications that address high-priority research areas identified by the NIH Office of AIDS Research, particularly focusing on the intersections of HIV/AIDS with hearing, communication, and associated disorders. Grants of up to $499,999 in direct costs are available for projects lasting up to five years, with no cost-sharing or matching requirements. Interested applicants, including educational institutions and community organizations, must adhere to NIH guidelines and submit their proposals through Grants.gov by the closing date of January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.